Barium Bioactive Glass Formulation: Novel Method
Tech ID
P27-1137
Patent Status
Granted in India
Design Status
--
Technical Description
The invention presents a potent ulcer treatment using rabeprazole-sodium combined with barium bioactive glass (BaBG) for enhanced drug effectiveness and sustained release.
Problems Addressed
- Adverse Effects of Conventional Treatment
- High Drug Dose
- High Manufacturing Time
- Costly Treatment
- High Infection Risk
- Nutritional Deficiencies Because of Conventional Treatment
TARGET AUDIENCE
- Pharmaceutical Industry
- Biomedical Industries
- Chemical Industry
- Materials Science Companies
TECH FEATURES
- Diverse Formulation Ingredients
- Improved Drug Efficiency
- Improved Relative Bioavailability
- Sustained Release Effect
- Rabeprazole-sodium loaded onto Barium Bioactive glass
P27-1137
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com